These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4402031)

  • 21. The effects of reserpine on behavior and on brain concentrations of serotonin and norepinephrine in control rats and rats with hypothalamic lesions.
    Grabarits F; Harvey JA
    J Pharmacol Exp Ther; 1966 Sep; 153(3):401-11. PubMed ID: 5921526
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of research in biogenic amines for the experimental psychopharmacology.
    Dlabac A
    Act Nerv Super (Praha); 1970; 12(3):215-25. PubMed ID: 4917578
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of intracerebroventricularly administered noradnamine and other sympathomimetic amines upon leptazol convulsions in mice.
    Jones BJ; Roberts DJ
    Br J Pharmacol; 1968 Sep; 34(1):27-31. PubMed ID: 4877601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turnover of brain adrenergic transmitters in Quaking mice.
    Kempf E; Greilsamer J; Mack G; Mandel P
    J Neurochem; 1973 Apr; 20(4):1269-73. PubMed ID: 4697887
    [No Abstract]   [Full Text] [Related]  

  • 28. Steric aspects of adrenergic drugs. XX. Accumulation of (-)- and (+)-norepinephrine- 14 C by peripheral tissues of the rat.
    Krell RD; Patil PN
    J Pharmacol Exp Ther; 1972 Aug; 182(2):273-83. PubMed ID: 5048364
    [No Abstract]   [Full Text] [Related]  

  • 29. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 30. Pentylenetetrazol induced clonic convulsions in rat. Role of brain monoamines.
    Bhattacharya SK; Ghosh P; Bose R
    Mater Med Pol; 1978; 10(3):184-7. PubMed ID: 31518
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):94-107. PubMed ID: 5072195
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of cocaine on the uptake of H3-norepinephrine and on the responses of isolated guinea-pig atria to sympathomimetic amines.
    Bhagat B; Bovell G; Robinson IM
    J Pharmacol Exp Ther; 1967 Mar; 155(3):472-8. PubMed ID: 6022621
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuronal localization of monoamines in the cerebral ganglia of the snail Helix pomatia.
    Bardessono F; Glacobini E; Stepita-Klauco M
    Brain Res; 1972 Dec; 47(2):427-37. PubMed ID: 4264629
    [No Abstract]   [Full Text] [Related]  

  • 34. Sympathomimetic amine-induced release of norepinephrine-3H from different intraneuronal storage compartments.
    Takimoto GS; Amiri BA; Cho AK
    Pharmacology; 1981; 23(6):310-25. PubMed ID: 7312941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of reserpine and sympathomimetic amines on hydroxytryptamine metabolism in blood platelets].
    Pletscher A; Da Prada M; Bartholini G
    Helv Physiol Pharmacol Acta; 1965 May; 65(1):C41-3. PubMed ID: 5317804
    [No Abstract]   [Full Text] [Related]  

  • 36. The isolated perfused rat brain as a model for brain monoamine research.
    Krieglstein J; Niemeyer DH
    J Neurochem; 1975 Apr; 24(4):829-31. PubMed ID: 1123644
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a butyrophenone derivative, U-32,802A, on brain biogenic amines.
    Lahti RA; Lednicer D
    Biochem Pharmacol; 1974 Jun; 23(12):1701-5. PubMed ID: 4842658
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the relation between the mechanism of action of several psychotropic substances and the cerebral levels of biogenic amines of their precursors].
    LEVY J; MICHEL-BER E
    Encephale; 1962; 51():132-48. PubMed ID: 14464771
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-hydroxytryptamine (5-HT) concentrations in the hippocampus, the hypothalamus and the medulla oblongata related to cisplatin-induced pica of rats.
    Liu Y; Hamaue N; Endo T; Hirafuji M; Minami M
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():97-113. PubMed ID: 15686111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.